Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer

Tien Hoang, KyungMann Kim, Anthony Jaslowski, Paul Koch, Peter Beatty, James McGovern, Maria Quisumbing, Gary Shapiro, Robert Witte, Joan H. Schiller

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences